HCPLive Network

Bone Loss Drugs Increase Stroke Risk in Patients with Cancer

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Article courtesy of http://www.onclive.com
 



Further Reading
Inflammatory bowel diseases have an impact on the prognosis of multiple sclerosis, according to a study published in PLOS One.
The brains of children and adolescents with attention deficit hyperactivity disorder (ADHD) are slower to develop some key connections, according to a study published in the Proceedings of the National Academy of Sciences.
The Medical College Admission Test has been revised, and the latest changes, including more humanities such as social sciences, are due to be implemented next April, according to a report from the Association of American Medical Colleges.
The risk of type 1 diabetes is increased for children diagnosed with enterovirus infection, according to a study published online Oct. 17 in Diabetologia.
The incidence of young-onset colorectal cancer is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American College of Gastroenterology, held from Oct. 17 to 22 in Philadelphia.
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
An Australian study casts doubt on the notion that a more gradual approach to weight loss is always the most effective route to take. The findings were published online Oct. 16 in The Lancet Diabetes & Endocrinology.
More Reading